Companies: 10,795·Total market cap: $144.5T
Karuna Therapeutics, Inc.

Karuna Therapeutics, Inc.

KRTXNASDAQHealthcare
$329.83
+$0.09(+0.03%)
Market Cap$12.6B
P/E Ratio
52W High$329.99
52W Low$158.375
Overview

Karuna Therapeutics, Inc. (KRTX) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · KRTX · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-11.39krtx eps ttm · krtx earnings per shareEarnings history
PE Ratio (TTM)krtx pe ratio ttm · krtx price to earningsPE Ratio deep dive
Revenue (TTM)654000.00krtx revenue ttm · krtx annual revenueFull revenue history
Dividend YieldNo Dividenddoes krtx pay dividends · krtx dividend yieldDividend history
Shares Outstanding37.0Mkrtx shares outstanding · krtx floatShares outstanding history
Next EarningsTBAkrtx earnings date · krtx next earningsEarnings history

Financial Snapshot

Full Financials
FY 2023Revenue$654000.00▼ 93.85% YoY
202120222023
karuna therapeutics, inc. revenue · krtx revenue 2023
FY 2023Net Income-$433.7M▼ 56.94% YoY
202120222023
karuna therapeutics, inc. net income · krtx profit 2023
FY 2023EPS$-11.73▼ 34.21% YoY
202120222023
krtx eps · karuna therapeutics, inc. earnings per share 2023
TTM:Revenue: $654000.00Net Income: -$422.2MEPS: $-11.39View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy25 analystsis krtx a buy · krtx analyst rating
Strong Buy
0
Buy
16
Hold
9
Sell
0
Strong Sell
0
12-Month Price Target
$150.00Low
$329.83Current
$257.50Avg Target21.93% downside
$330.00High
krtx price target · krtx 12 month forecast

Total: 25 · Buy rate: 64.0%

The KRTX analyst consensus is Buy, based on ratings from 25 Wall Street analysts over the past 3 months. The average 12-month price target is $257.50, representing -21.93% downside from the current price of $329.83.

Stock Performance

Full History
1D+0.00%
1W+0.00%
1M+0.03%
3M+4.13%
YTD+4.79%
1Y+80.59%
5Y+1547.50%

About Karuna Therapeutics, Inc.

CEOWilliam Meury
IPO DateJun 28, 2019
Employees339
CountryUS

Karuna Therapeutics, Inc. Operating as a clinical-stage biopharmaceutical firm, Karuna Therapeutics, Inc. is dedicated to pioneering innovative therapies for individuals afflicted by psychiatric and neurological disorders. Its…

what is karuna therapeutics, inc. · krtx stock overview · karuna therapeutics, inc. company profile · who is karuna therapeutics, inc. ceo · krtx NASDAQ · karuna therapeutics, inc. headquarters · karuna therapeutics, inc. business segments

About Stock Overview & Key Data

Karuna Therapeutics, Inc. (KRTX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jun 28, 2019. As of the latest trading session, KRTX stock price is $329.83, with a market capitalization of $12.6B. The stock has returned +80.59% over the past 12 months and +4.79% year-to-date.

According to 25 Wall Street analysts, the consensus rating for Karuna Therapeutics, Inc. stock is Buy, with an average 12-month price target of $257.50. In fiscal year 2023, Karuna Therapeutics, Inc. reported revenue of $654000.00 and net income of -$433.7M. For detailed data — including Karuna Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Karuna Therapeutics, Inc. (KRTX) stock price is $329.83. The stock is traded on NASDAQ under the ticker symbol KRTX. The 52-week range is $158.38 – $329.99.

KRTX stock priceKRTX quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice